Anna Kathy Aman

Array ( [id] => 10586599 [patent_doc_number] => 09308195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-12 [patent_title] => 'Non-aqueous taxane formulations and methods of using the same' [patent_app_type] => utility [patent_app_number] => 14/564384 [patent_app_country] => US [patent_app_date] => 2014-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17634 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14564384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13645599 [patent_doc_number] => 09849098 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-26 [patent_title] => Compositions and methods for treating respiratory injury or disease [patent_app_type] => utility [patent_app_number] => 15/102827 [patent_app_country] => US [patent_app_date] => 2014-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 41 [patent_no_of_words] => 20578 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10265852 [patent_doc_number] => 20150150850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'TREATING CANCER WITH HSP90 INHIBITORY COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/561270 [patent_app_country] => US [patent_app_date] => 2014-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26618 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14561270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12424815 [patent_doc_number] => 09974776 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-22 [patent_title] => Estrogen receptor beta agonists for use in treating mesothelioma [patent_app_type] => utility [patent_app_number] => 15/101132 [patent_app_country] => US [patent_app_date] => 2014-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 13244 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15101132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10326071 [patent_doc_number] => 20150211073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'MRNA-BASED GENE EXPRESSION FOR PERSONALIZING PATIENT CANCER THERAPY WITH AN MDM2 ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 14/560519 [patent_app_country] => US [patent_app_date] => 2014-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28677 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14560519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11408828 [patent_doc_number] => 09556120 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-31 [patent_title] => 'Compositions for modulating a kinase cascade and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 14/554495 [patent_app_country] => US [patent_app_date] => 2014-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 28 [patent_no_of_words] => 44821 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14554495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10202670 [patent_doc_number] => 20150087659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'NOVEL INHIBITORS OF SECRETION OF HEPATITIS B VIRUS ANTIGENS' [patent_app_type] => utility [patent_app_number] => 14/549777 [patent_app_country] => US [patent_app_date] => 2014-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11614 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14549777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10256459 [patent_doc_number] => 20150141456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'CYCLIC AMINO COMPOUNDS FOR USE IN THE TREATMENT OF CARDIAC DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/549414 [patent_app_country] => US [patent_app_date] => 2014-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19763 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14549414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11099545 [patent_doc_number] => 20160296516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-13 [patent_title] => 'HYDROMORPHONE AND NALOXONE FOR TREATMENT OF PAIN AND OPIOID BOWEL DYSFUNCTION SYNDROME' [patent_app_type] => utility [patent_app_number] => 15/036735 [patent_app_country] => US [patent_app_date] => 2014-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 29185 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11879567 [patent_doc_number] => 09750723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-05 [patent_title] => 'Prevention and treatment of non-alcoholic fatty liver disease' [patent_app_type] => utility [patent_app_number] => 15/032508 [patent_app_country] => US [patent_app_date] => 2014-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12927 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15032508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11914235 [patent_doc_number] => 09782409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-10 [patent_title] => 'Treatment of cancer and benign proliferative disorders' [patent_app_type] => utility [patent_app_number] => 15/031209 [patent_app_country] => US [patent_app_date] => 2014-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 15 [patent_no_of_words] => 20026 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15031209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11296675 [patent_doc_number] => 09504667 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-29 [patent_title] => 'Method for treating skin cancer' [patent_app_type] => utility [patent_app_number] => 14/519510 [patent_app_country] => US [patent_app_date] => 2014-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7043 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14519510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11060718 [patent_doc_number] => 20160257680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'ISOTOPICALLY LABELED TRIAZOLOPYRIDINE 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/031301 [patent_app_country] => US [patent_app_date] => 2014-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9837 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15031301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11059471 [patent_doc_number] => 20160256434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'USE OF STING AGONISTS TO TREAT HEPATITIS B VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 15/028813 [patent_app_country] => US [patent_app_date] => 2014-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9276 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15028813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10018542 [patent_doc_number] => 09061011 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-06-23 [patent_title] => 'Bendamustine pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 14/519079 [patent_app_country] => US [patent_app_date] => 2014-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 17432 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14519079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11066121 [patent_doc_number] => 20160263086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-15 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 15/030713 [patent_app_country] => US [patent_app_date] => 2014-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 27136 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10226932 [patent_doc_number] => 20150111926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'SYNERGISTIC PESTICIDAL COMPOSITIONS AND RELATED METHODS' [patent_app_type] => utility [patent_app_number] => 14/517235 [patent_app_country] => US [patent_app_date] => 2014-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9665 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14517235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10202732 [patent_doc_number] => 20150087720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'Dosage Regimen of an S1P Receptor Agonist' [patent_app_type] => utility [patent_app_number] => 14/516153 [patent_app_country] => US [patent_app_date] => 2014-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7270 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14516153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11059479 [patent_doc_number] => 20160256441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'MODULATION OF MRTF-A ACTIVITY IN PATHOLOGIC FIBROSIS AND WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 15/029222 [patent_app_country] => US [patent_app_date] => 2014-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22317 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10331820 [patent_doc_number] => 20150216824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-06 [patent_title] => 'Treatment of Medium-Chain Acyl-CoA Dehydrogenase Deficiency' [patent_app_type] => utility [patent_app_number] => 14/515298 [patent_app_country] => US [patent_app_date] => 2014-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7243 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14515298 [rel_patent_id] =>[rel_patent_doc_number] =>)